Company: IMNN
Filing Date: 2025-03-19
Form Type: DRS
Source: 0001641172-25-000007
Chunk: 56

Company: Imunon, Inc.
Filing Date: 2025-03-19
Form: DRS
Chunk 56
---
, filed on July 31, 2024 (SEC File No. 001-15911).                                                                                                                                                                                                                              |
| 10.30

#  |     | Form                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
 of Securities Purchase Agreement.                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

| II-5 |

| CONFIDENTIAL TREATMENT REQUESTED BY IMUNON, INC.PURSUANT TO 17 C.F.R. SECTION 200.83 |

| 21.1  |     | Subsidiaries of Imunon, Inc., incorporated by reference to Exhibit 21.1 to the Annual Report on Form 10-K of the Company for the year ended December 31, 2024 (SEC File No. 001-15911). |
| 23.1

# |     | Consent                                                                                                                                                                                 
 of WithumSmith+Brown, PC, independent registered public accounting firm for the Company.                                                                                                |
| 23.2

# |     | Consent                                                                                                                                                                                 
 of Thompson Hine LLP (included in Exhibit 5.1).                                                                                                                                         |
| 24.1

# |     | Power of Attorney (included on signature page hereto).                                                                                                                                  |
| 107

#  |     | Filing                                                                                                                                                                                  
 Fee Table.                                                                                                                                                                              |

| *  | Portions                                                                                                                           
 of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act 
 of 1934, amended, and the omitted material has been separately filed with the Securities and Exchange Commission.                  |
| ** | Management                                                                                                                         
 contract or compensatory plan or arrangement.                                                                                      |
| 

#  | To                                                                                                                                 
 be filed by amendment.                                                                                                             |

Item 17. Undertakings.

The undersigned registrant hereby undertakes:

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i) To include any prospectus required by Section 10(a)(3) of the Securities Act;

(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high